Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.
about
Overcoming tumor immune evasion with an unique arbovirusDifferential response of primary and immortalized CD4+ T cells to Neisseria gonorrhoeae-induced cytokines determines the effect on HIV-1 replication.Microbe-host interactions: structure and role of Gram-negative bacterial porinsNeuropharmacology of N,N-dimethyltryptamineReduced DICER1 elicits an interferon response in endometrial cancer cellspEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlationsIFNB1/interferon-β-induced autophagy in MCF-7 breast cancer cells counteracts its proapoptotic function.Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy.Higher miRNA tolerance in immortal Li-Fraumeni fibroblasts with abrogated interferon signaling pathway.Metastatic type 1 gastric carcinoid: a real threat or just a myth?Influence of interferon-alpha combined with chemo (radio) therapy on immunological parameters in pancreatic adenocarcinoma.Role of biological targeted therapies in gastroenteropancreatic neuroendocrine tumours.Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance.A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.Erlotinib: early clinical development in brain cancer.Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells.IFN-β is a potent inhibitor of insulin and insulin like growth factor stimulated proliferation and migration in human pancreatic cancer cells.SHP-2 phosphatase promotes cervical cancer cell proliferation through inhibiting interferon-β production.Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas.DTNQ-Pro, a Mimetic Dipeptide, Sensitizes Human Colon Cancer Cells to 5-Fluorouracil Treatment.Clinical and pathological characteristics of giant cell angioblastoma: a case report.Increased interaction between PACT molecules in response to stress signals is required for PKR activation.
P2860
Q28081774-A78C774B-F9EE-441C-A7BD-A66063C51D2EQ33883419-AD05C7AA-DCD7-4030-AD9D-D80536B1F66DQ34321941-F6D43631-AC4F-4A12-820E-9C73D5A9F2DBQ34524116-958B25A6-5E56-451D-AF87-48E5B8912F35Q35840362-AD9D002B-9367-4D7B-A7D9-9B535FF192EBQ36289932-2A9B0D74-6E81-440E-B20F-8C8D10AAC7D8Q36662334-EC99EB7A-E3E6-458A-ACF3-0F99BF7A92DDQ36819237-8459EBE1-EABD-4D9C-816A-A776469187EDQ37337916-4DAF012F-E706-4561-BADD-3E66A9DC8FB3Q37408868-50D15934-F65B-4FFA-B9B5-DF42A41FEBA7Q37684031-E44FDABE-8083-4173-80DB-B4DA8873E8AEQ37922650-DFFA6DAD-3F00-4A5E-A327-A68769ACA2E4Q37962416-0525A905-5068-4E0F-9C57-F8BE22C6EE72Q38071119-83BA0B3D-3D9D-4B7F-BF0B-EF86C52C7352Q38101865-1CDEEB84-952B-4293-B37B-01767305BED8Q38212394-C0AAD7E4-F0F8-497D-A4CA-7F1AE8BFF825Q38281748-70D45649-9305-4F23-AFB0-626B7D82ADCDQ38844045-3245581F-8A68-4C21-AB8F-AAD6793954C1Q39298327-A6FCE554-A205-4A44-93F9-67441F0E6CF8Q39502676-D65171FA-728E-489C-8AEA-1EC850F567D5Q40715421-739BA4EF-E6F6-4037-B4B4-7EAD4282D917Q42130520-74B6A6D0-809C-4588-81D1-0E68CA100370Q54519466-F8ECDF1E-EEEC-4E29-9E92-45E68A1B9BDC
P2860
Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging strategies to strengt ...... overcoming survival pathways.
@en
Emerging strategies to strengt ...... overcoming survival pathways.
@nl
type
label
Emerging strategies to strengt ...... overcoming survival pathways.
@en
Emerging strategies to strengt ...... overcoming survival pathways.
@nl
prefLabel
Emerging strategies to strengt ...... overcoming survival pathways.
@en
Emerging strategies to strengt ...... overcoming survival pathways.
@nl
P2093
P50
P1476
Emerging strategies to strengt ...... : overcoming survival pathways
@en
P2093
A Abbruzzese
F Cavagnini
L J Hofland
P Tagliaferri
S W J Lamberts
S Zappavigna
P304
P356
10.2174/156800909789056980
P577
2009-08-01T00:00:00Z